Cargando…

The infectivity of progeny adenovirus in the presence of neutralizing antibody

Human adenoviruses (Ads), common pathogens that cause upper respiratory and gastrointestinal infections, are blocked by neutralizing antibodies (nAbs). However, Ads are not fully eliminated even in hosts with nAbs. In this study, we assessed the infectivity of progeny Ad serotype 5 (Ad5) in the pres...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirai, Takamasa, Sato, Anna, Koizumi, Naoya, Kurioka, Yoh, Suzuki, Yui, Kano, Junpei, Yamakawa, Makie, Nomura, Tetsuya, Fujii, Makiko, Sakurai, Fuminori, Mizuguchi, Hiroyuki, Watanabe, Yoshiteru, Utoguchi, Naoki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Microbiology Society 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8290266/
https://www.ncbi.nlm.nih.gov/pubmed/33843575
http://dx.doi.org/10.1099/jgv.0.001590
_version_ 1783724462189838336
author Hirai, Takamasa
Sato, Anna
Koizumi, Naoya
Kurioka, Yoh
Suzuki, Yui
Kano, Junpei
Yamakawa, Makie
Nomura, Tetsuya
Fujii, Makiko
Sakurai, Fuminori
Mizuguchi, Hiroyuki
Watanabe, Yoshiteru
Utoguchi, Naoki
author_facet Hirai, Takamasa
Sato, Anna
Koizumi, Naoya
Kurioka, Yoh
Suzuki, Yui
Kano, Junpei
Yamakawa, Makie
Nomura, Tetsuya
Fujii, Makiko
Sakurai, Fuminori
Mizuguchi, Hiroyuki
Watanabe, Yoshiteru
Utoguchi, Naoki
author_sort Hirai, Takamasa
collection PubMed
description Human adenoviruses (Ads), common pathogens that cause upper respiratory and gastrointestinal infections, are blocked by neutralizing antibodies (nAbs). However, Ads are not fully eliminated even in hosts with nAbs. In this study, we assessed the infectivity of progeny Ad serotype 5 (Ad5) in the presence of nAb. The infectivity of Ad5 was evaluated according to the expression of the Ad genome and reporter gene. Infection by wild-type Ad5 and Ad5 vector continued to increase until 3 days after infection even in the presence of nAb. We established an assay for determining the infection levels of progeny Ad5 using a sorting system with magnetic beads and observed little difference in progeny Ad5 counts in the presence and absence of nAb 1 day after infection. Moreover, progeny Ad5 in the presence of nAb more effectively infected coxsackievirus and adenovirus receptor (CAR)-positive cells than CAR-negative cells. We investigated the function of fiber proteins, which are the binding partners of CAR, during secondary infection, observing that fibre proteins spread from infected cells to adjacent cells in a CAR-dependent manner. In conclusion, this study revealed that progeny Ad5 could infect cells even in the presence of nAb, differing from the common features of the Ad5 infection cycle. Our findings may be useful for developing new therapeutic agents against Ad infection.
format Online
Article
Text
id pubmed-8290266
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Microbiology Society
record_format MEDLINE/PubMed
spelling pubmed-82902662021-07-20 The infectivity of progeny adenovirus in the presence of neutralizing antibody Hirai, Takamasa Sato, Anna Koizumi, Naoya Kurioka, Yoh Suzuki, Yui Kano, Junpei Yamakawa, Makie Nomura, Tetsuya Fujii, Makiko Sakurai, Fuminori Mizuguchi, Hiroyuki Watanabe, Yoshiteru Utoguchi, Naoki J Gen Virol Animal Human adenoviruses (Ads), common pathogens that cause upper respiratory and gastrointestinal infections, are blocked by neutralizing antibodies (nAbs). However, Ads are not fully eliminated even in hosts with nAbs. In this study, we assessed the infectivity of progeny Ad serotype 5 (Ad5) in the presence of nAb. The infectivity of Ad5 was evaluated according to the expression of the Ad genome and reporter gene. Infection by wild-type Ad5 and Ad5 vector continued to increase until 3 days after infection even in the presence of nAb. We established an assay for determining the infection levels of progeny Ad5 using a sorting system with magnetic beads and observed little difference in progeny Ad5 counts in the presence and absence of nAb 1 day after infection. Moreover, progeny Ad5 in the presence of nAb more effectively infected coxsackievirus and adenovirus receptor (CAR)-positive cells than CAR-negative cells. We investigated the function of fiber proteins, which are the binding partners of CAR, during secondary infection, observing that fibre proteins spread from infected cells to adjacent cells in a CAR-dependent manner. In conclusion, this study revealed that progeny Ad5 could infect cells even in the presence of nAb, differing from the common features of the Ad5 infection cycle. Our findings may be useful for developing new therapeutic agents against Ad infection. Microbiology Society 2021-04-12 /pmc/articles/PMC8290266/ /pubmed/33843575 http://dx.doi.org/10.1099/jgv.0.001590 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution NonCommercial License.
spellingShingle Animal
Hirai, Takamasa
Sato, Anna
Koizumi, Naoya
Kurioka, Yoh
Suzuki, Yui
Kano, Junpei
Yamakawa, Makie
Nomura, Tetsuya
Fujii, Makiko
Sakurai, Fuminori
Mizuguchi, Hiroyuki
Watanabe, Yoshiteru
Utoguchi, Naoki
The infectivity of progeny adenovirus in the presence of neutralizing antibody
title The infectivity of progeny adenovirus in the presence of neutralizing antibody
title_full The infectivity of progeny adenovirus in the presence of neutralizing antibody
title_fullStr The infectivity of progeny adenovirus in the presence of neutralizing antibody
title_full_unstemmed The infectivity of progeny adenovirus in the presence of neutralizing antibody
title_short The infectivity of progeny adenovirus in the presence of neutralizing antibody
title_sort infectivity of progeny adenovirus in the presence of neutralizing antibody
topic Animal
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8290266/
https://www.ncbi.nlm.nih.gov/pubmed/33843575
http://dx.doi.org/10.1099/jgv.0.001590
work_keys_str_mv AT hiraitakamasa theinfectivityofprogenyadenovirusinthepresenceofneutralizingantibody
AT satoanna theinfectivityofprogenyadenovirusinthepresenceofneutralizingantibody
AT koizuminaoya theinfectivityofprogenyadenovirusinthepresenceofneutralizingantibody
AT kuriokayoh theinfectivityofprogenyadenovirusinthepresenceofneutralizingantibody
AT suzukiyui theinfectivityofprogenyadenovirusinthepresenceofneutralizingantibody
AT kanojunpei theinfectivityofprogenyadenovirusinthepresenceofneutralizingantibody
AT yamakawamakie theinfectivityofprogenyadenovirusinthepresenceofneutralizingantibody
AT nomuratetsuya theinfectivityofprogenyadenovirusinthepresenceofneutralizingantibody
AT fujiimakiko theinfectivityofprogenyadenovirusinthepresenceofneutralizingantibody
AT sakuraifuminori theinfectivityofprogenyadenovirusinthepresenceofneutralizingantibody
AT mizuguchihiroyuki theinfectivityofprogenyadenovirusinthepresenceofneutralizingantibody
AT watanabeyoshiteru theinfectivityofprogenyadenovirusinthepresenceofneutralizingantibody
AT utoguchinaoki theinfectivityofprogenyadenovirusinthepresenceofneutralizingantibody
AT hiraitakamasa infectivityofprogenyadenovirusinthepresenceofneutralizingantibody
AT satoanna infectivityofprogenyadenovirusinthepresenceofneutralizingantibody
AT koizuminaoya infectivityofprogenyadenovirusinthepresenceofneutralizingantibody
AT kuriokayoh infectivityofprogenyadenovirusinthepresenceofneutralizingantibody
AT suzukiyui infectivityofprogenyadenovirusinthepresenceofneutralizingantibody
AT kanojunpei infectivityofprogenyadenovirusinthepresenceofneutralizingantibody
AT yamakawamakie infectivityofprogenyadenovirusinthepresenceofneutralizingantibody
AT nomuratetsuya infectivityofprogenyadenovirusinthepresenceofneutralizingantibody
AT fujiimakiko infectivityofprogenyadenovirusinthepresenceofneutralizingantibody
AT sakuraifuminori infectivityofprogenyadenovirusinthepresenceofneutralizingantibody
AT mizuguchihiroyuki infectivityofprogenyadenovirusinthepresenceofneutralizingantibody
AT watanabeyoshiteru infectivityofprogenyadenovirusinthepresenceofneutralizingantibody
AT utoguchinaoki infectivityofprogenyadenovirusinthepresenceofneutralizingantibody